Rahsaan Thompson - 21 Jun 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Chief Legal & Compliance, Secretary
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Rahsaan W. Thompson
Issuer symbol
ZVRA
Transactions as of
21 Jun 2025
Net transactions value
$0
Form type
4
Filing time
24 Jun 2025, 17:28:38 UTC
Previous filing
03 Feb 2025
Next filing
30 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Thompson Rahsaan Chief Legal & Compliance, Secretary C/O ZEVRA THERAPEUTICS, INC., 1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Rahsaan W. Thompson 24 Jun 2025 0001788524

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Options Exercise +66,666 66,666 21 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Restricted Stock Unit Options Exercise $0 -66,666 -33% $0.000000 133,334 21 Jun 2025 Common Stock 66,666 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The first tranche of the restricted stock units vested and settled on June 21, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney